United States · Resolution · HRES
H.Res. 803 (119th)
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Introduced
10 October 2025
Last action
—
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
15 December 2025
Records
Official resolution H.Res. 803 (119th) from United States at United States Congress. Dated 10 October 2025. Status: Referred to the House Committee on Energy and Commerce..
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in House
Introduced in House
Introduced in House · EN · 10 October 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/119th-congress/house-resolution/803
- Open data entity: https://api.congress.gov/v3/bill/119/hres/803